LQDA Q2 2019 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+674.0% YoY

Gross Profit

$7M90.0% margin

Operating Income

-$6M-72.7% margin

Net Income

-$6M-73.1% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$821,845

Balance Sheet

Total Assets

$65M

Total Liabilities

$33M

Stockholders' Equity

$32M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$1M	+674.0%
Gross Profit	$7M	$948,537	+665.9%
Operating Income	-$6M	-$7M	+15.7%
Net Income	-$6M	-$6M	+5.9%

Revenue Segments

Collaboration And Licensing Non Refundable Upfront Payments

$7M83%

Collaboration And Licensing Milestones

$1M17%

Research And Development Services

$2000%